- 同
- VZIG, VariZIG
- 同
- VZIG
WordNet
- secure against; "immune from taxation as long as he resided in Bermuda"; "immune from criminal prosecution"
- a person who is immune to a particular infection
- relating to or conferring immunity (to disease or infection) (同)resistant
- (usually followed by `to'
- relating to the condition of immunity; "the immune system"
- a family of proteins found in blood and milk and muscle and in plant seed
PrepTutorEJDIC
- 免疫の / 《補語にのみ用いて》(影響・攻撃・義務・税などを)免れている《+『against』(『from, to』)+『名』》
- グロブリン(動植物組織内の純蛋白(たんぱく)質の総称)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 水痘帯状疱疹ウイルス感染に対する暴露後予防 post exposure prophylaxis against varicella zoster virus infection
- 2. 妊娠中の水痘帯状疱疹ウイルス感染 varicella zoster virus infection in pregnancy
- 3. 新生児における水痘帯状疱疹ウイルス感染症 varicella zoster infection in the newborn
- 4. 病院における水痘の予防および管理 prevention and control of varicella in hospitals
- 5. 免疫不全症の内科的マネージメント medical management of immune deficiency
English Journal
- Updated recommendations for use of VariZIG--United States, 2013.
- Centers for Disease Control and Prevention (CDC).AbstractIn December 2012, the Food and Drug Administration (FDA) approved VariZIG, a varicella zoster immune globulin preparation (Cangene Corporation, Winnipeg, Canada) for use in the United States for postexposure prophylaxis of varicella for persons at high risk for severe disease who lack evidence of immunity to varicella* and for whom varicella vaccine is contraindicated. Previously available under an investigational new drug (IND) expanded access protocol, VariZIG, a purified immune globulin preparation made from human plasma containing high levels of anti-varicella-zoster virus antibodies (immunoglobulin G), is the only varicella zoster immune globulin preparation currently available in the United States. VariZIG is now approved for administration as soon as possible following varicella-zoster virus exposure, ideally within 96 hours (4 days) for greatest effectiveness. CDC recommends administration of VariZIG as soon as possible after exposure to the varicella-zoster virus and within 10 days. CDC also has revised the patient groups recommended by the Advisory Committee on Immunization Practices (ACIP) to receive VariZIG by extending the period of eligibility for previously recommended premature infants from exposures to varicella-zoster virus during the neonatal period to exposures that occur during the entire period for which they require hospital care for their prematurity. The CDC recommendations for VariZIG use are now harmonized with the American Academy of Pediatrics (AAP) recommendations. This report summarizes data on the timing of administration of varicella zoster immune globulin in relation to exposure to varicella-zoster virus and provides the CDC updated recommendations for use of VariZIG that replace the 2007 ACIP recommendations.
- MMWR. Morbidity and mortality weekly report.MMWR Morb Mortal Wkly Rep.2013 Jul 19;62(28):574-6.
- In December 2012, the Food and Drug Administration (FDA) approved VariZIG, a varicella zoster immune globulin preparation (Cangene Corporation, Winnipeg, Canada) for use in the United States for postexposure prophylaxis of varicella for persons at high risk for severe disease who lack evidence of im
- PMID 23863705
- Varicella, influenza: not necessary to separate mother and infant.
- Sendelbach DM, Sanchez PJ.
- Pediatrics.Pediatrics.2012 Aug;130(2):e464; author reply 465-6. doi: 10.1542/peds.2012-1647E.
- PMID 22855925
- Chickenpox in the immunocompromised child.
- Roderick M, Finn A, Ramanan AV.SourceDepartment of Paediatric Rheumatology, Bristol Royal Hospital for Children, 23 Hillview, Henleaze, Bristol BS9 4QD, UK.
- Archives of disease in childhood.Arch Dis Child.2012 Jul;97(7):587-9. doi: 10.1136/archdischild-2012-301684. Epub 2012 May 4.
- PMID 22563036
Japanese Journal
- 三叉神経第 3 枝領域に発生した帯状疱疹の 1 例 : 高齢者に対する抗ウイルス剤の使用経験
- 上村 俊介,金川 昭啓,岡 淳子 デボラ
- 九州齒科學會雜誌 : Kyushu-Shika-Gakkai-zasshi 45(5), 619-624, 1991-10-25
- … Herpes zoster is the viral disease of skin and mucosa caused by Varicella-zoster virus and characterized by grouped vesicles and eruptions along a peripheral nerve. … We presented a case of herpes zoster affecting the third branches of the right trigeminal nerve of a 73-year-old female. … The case was treated by immune globulin at first and the effect seemed to be favorable against vesicles and eruptions of skin. …
- NAID 110003006705
Related Links
- Varicella-zoster immune globulin (VZIG) A substance that can reduce the severity of chickenpox symptoms. Mentioned in: Chickenpox varicella-zoster immune globulin (VZIG) [zos′tər] Etymology: L, varius, diverse; Gk, zoster, girdle ...
- glob·u·lin (glŏb′yə-lĭn) n. Any of a class of proteins that are widespread in blood plasma, milk, muscle, and plant seeds and that are insoluble in pure water but soluble in dilute salt solutions. [globul(e) + -in.] globulin (ˈɡlɒbjʊlɪn) n 1. ...
Related Pictures
★リンクテーブル★
| リンク元 | 「VZIG」「VariZIG」 |
| 関連記事 | 「immune」「globuli」「immune globulin」「varicella zoster」 |
「VZIG」
「VariZIG」
「immune」
- adj.
- 免疫の、免疫性の
「globuli」
- np.
「immune globulin」
[★] 免疫グロブリン Ig immunoglobulins Igs
「varicella zoster」
- 関
- VZ